Department of Emergency Medicine, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Department of Interventional Radiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
J Clin Lab Anal. 2021 Jun;35(6):e23801. doi: 10.1002/jcla.23801. Epub 2021 May 6.
Thrombotic complications following splenectomy have been documented. However, there has been sparse literature regarding thrombotic complications following splenic artery embolization (SAE).The objective of this study was to determine changes in coagulation and fibrinolysis and assess the thrombotic risk after SAE in patients with blunt splenic injury (BSI).
This study included 38 BSI patients who were hemodynamically stable on admission. SAE was performed if the splenic injury was classed as grade III or greater and had no requirement of immediate surgery. Platelet (PLT), fibrinogen (FIB), D-dimers (D-D), fibrinogen/fibrin degradation products (FDP), antithrombin III (AT III), prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT), hemoglobin (Hb), and hematocrit (Hct) were measured before SAE procedures and then 1d, 3d, and 7d after SAE.
The technical success rate of SAE and the splenic salvage rate were 100%. There was no mortality. Compared with pre-SAE values, the levels of PLT, FIB, D-D, and FDP increased significantly at 3 days and 7 days after SAE (p < 0.05). However, AT III, PT, APTT, TT, Hb, and Hct showed no statistically significant difference at 1d, 3d, and 7d after SAE (p > 0.05).
Alterations in PLT and hemostatic parameters might contribute to the increased risk of thrombotic complications in BSI patients undergoing SAE. Thromboembolism following SAE should be considered and thrombotic prophylaxis should be recommended.
脾切除术后有血栓并发症的记录。然而,关于脾动脉栓塞(SAE)后血栓并发症的文献很少。本研究的目的是确定钝性脾损伤(BSI)患者 SAE 后凝血和纤溶的变化,并评估血栓形成风险。
本研究纳入了 38 例入院时血流动力学稳定的 BSI 患者。如果脾损伤分级为 III 级或更高级别,且不需要立即手术,则进行 SAE。在 SAE 前测量血小板(PLT)、纤维蛋白原(FIB)、D-二聚体(D-D)、纤维蛋白原/纤维蛋白降解产物(FDP)、抗凝血酶 III(AT III)、凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)、血红蛋白(Hb)和血细胞比容(Hct),然后在 SAE 后 1d、3d 和 7d 再次测量。
SAE 的技术成功率和脾保留率均为 100%。无死亡病例。与 SAE 前值相比,PLT、FIB、D-D 和 FDP 在 SAE 后 3d 和 7d 时显著升高(p<0.05)。然而,AT III、PT、APTT、TT、Hb 和 Hct 在 SAE 后 1d、3d 和 7d 时无统计学差异(p>0.05)。
PLT 和止血参数的改变可能导致 SAE 后 BSI 患者发生血栓并发症的风险增加。应考虑 SAE 后发生血栓栓塞,并建议进行血栓预防。